In this issue:
XTEND-1: Efanesoctocog alfa efficacious in severe haemophilia A
PREVENT-CLOT: aspirin vs heparin for death prevention after fracture
TORADI-HIT tool may improve HIT diagnosis
High risk of thrombosis in myeloma
Traumatic coagulopathy in the older patient
Tinzaparin for VTE patients with renal impairment
Validation of ONKOTEV for cancer-associated thrombosis risk
Incidence of thrombosis in nitrous oxide addicts
Antithrombotic therapy challenging in HHT with high morbidity
36-month clinical outcomes of patients with VTE
Please login below to download this issue (PDF)